Form 483

Zermat Internacional, S.A. de C.V. Form 483, 2022-10-14

FDA issued a Form 483 to Zermat Internacional, S.A. de C.V. on 2022-10-14 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Zermat Internacional, S.A. de C.V. · Tlalnepantla, Mexico · Issued October 14, 2022

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Oct 2022
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Christopher M Jenner, Tiara M Brown

14 Oct 2022
21 CFR 211.160(b)(1)

Incoming lots - conformance to written specs-

Cited by Christopher M Jenner, Tiara M Brown

14 Oct 2022
21 CFR 211.188(b)

Batch production and Batch Control Record Requirements

Cited by Christopher M Jenner, Tiara M Brown

14 Oct 2022
21 CFR 211.22(a)

Lack of quality control unit

Cited by Christopher M Jenner, Tiara M Brown

14 Oct 2022
21 CFR 211.68(b)

Backup data not assured as exact and complete

Cited by Christopher M Jenner, Tiara M Brown

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere